Viewing Study NCT02014259


Ignite Creation Date: 2025-12-24 @ 2:42 PM
Ignite Modification Date: 2026-01-31 @ 8:28 PM
Study NCT ID: NCT02014259
Status: COMPLETED
Last Update Posted: 2018-04-19
First Post: 2013-12-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module